EpiCombi.AI Company
EpiCombi.AI is a genomics signature-driven therapeutics spinout from Oxford University, is overcoming epigenetic barriers in cancer complexity through the creation of AI-derived, network-acting multi-targeted drugs.
Technology:
AI-driven Drug Target Identification
Industry:
BioPharma AI
Founded Date:
2017-01-01 00:00:00
Headquarters:
Oxford,Oxfordshire,United Kingdom,Europe
Funding Status:
private